Blood thinners may boost survival for prostate cancer patients

Men with advanced prostate cancer might live longer when they are taking blood-thinning medication, a small study suggests. Prostate cancer patients who were also taking a blood thinner, usually to stave off a blood clot, had a 39 percent increase in overall survival over men who were not taking these drugs, report researchers from the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore. The findings were presented this month by Caroline Pratz and colleagues at an American Society of Clinical Oncology (ASCO) conference in Orlando, Fla. Read more here.